RN
REC Silicon ASA
RNWEY · OTC
$0.00 +0.00% (+$0.00)
Market Cap $410.2K
P/E Ratio -
Div. Yield 300.00%
ROE 89.01%
Bulios Fair Price
$0
100.0% downside
Current Price
$0.001
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RNWEY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap EV/EBITDA 0.18x
P/S 0.00x
P/E N/A
Growth
66 /100
Stable Rev. growth 4.94%
Book val. growth 9.00%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 70.76%
Net margin 408.76%
Op. margin 40.27%
Quality
72 /100
Excellent ROIC 11.56%
ROE 89.01%
ROA 238.58%
Debt
50 /100
Moderate Current ratio 0.10x
Int. coverage -0.87x
Net debt/EBITDA 0.17x
Stability
32 /100
Unstable Beta 0.10x
Rev. volatility 11.06%
EPS volatility 151.53%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RNWEY
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Kurt Levens
Employees
495
Headquarters
Lysaker